|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-POR-15007170 |
|
Date of registration:
|
2015-10-03 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The effect of dexmedetomidine on human dendritic cells
|
|
Scientific title:
|
Dexmedetomidine inhibits maturation andfunction of human cord blood-derived dendritic cells by interfering with synthesis andsecretion of IL-12 andIL-23 |
|
Date of first enrolment:
|
2015-10-08 |
|
Target sample size:
|
dexmedetomidine group, dexmedetomidine plus yohimbine (dexmedetomidine inhibitor) group andcontrol group:20; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=12057 |
|
Study type:
|
Prognosis study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Other
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Gong Chen
|
|
Address:
|
138 Tongzipo Road, Changsha, Hunan, China
|
|
Telephone:
|
+86 13786127630 |
|
Email:
|
chengong86@foxmail.com |
|
Affiliation:
|
The third Xiangya Hospital of Central South University |
|
|
Name:
|
Wen Ouyang
|
|
Address:
|
138 Tongzipo Road, Changsha, Hunan, China
|
|
Telephone:
|
+86 13974934441 |
|
Email:
|
ouyangwen133@vip.sina.com |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: healthy puerperant
Exclusion criteria: 1. endocrine diseases such as diabetes, hyperthyroidism;
2. pregnancy medication history;
3. Premature rupture of membranes
Age minimum:
25
Age maximum:
32
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
breast carcinoma
|
|
Intervention(s)
|
|
dexmedetomidine group, dexmedetomidine plus yohimbine (dexmedetomidine inhibitor) group andcontrol group:dexmedetomidine vs dexmedetomidine plus yohimbine;
|
|
Primary Outcome(s)
|
|
IL-12;
|
|
Source(s) of Monetary Support
|
|
National Natural Science Foundation of China
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|